Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio

Perinatal Outcomes in Patients With Suspicion of Preeclampsia and Elevated sFlt-1/PlGF Before Term: A Retrospective Cohort Study

Retrospective cohort study that evaluated 190 subjects admitted with diagnosis of hypertensive disorder of pregnancy, between 24 and 36 6/7 weeks, with an sFlt-1/PlGF index greater than or equal to 110. Data were collected on their clinical course prior to termination of pregnancy, using the last reported sFlt-1/PlGF ratio value to classify the population into four cohorts: values between 110-205, between 206 and 654, between 655 and 999 and greater than 1000.

Inclusion Criteria:

• Diagnosis of hypertensive disorder of pregnancy
• Gestational age between 24 - 36 6/7
• sFlt-1/PlGF > 110

Exclusion Criteria:

• Gestational age below 23 6/7 weeks and above 37 weeks at the moment of admission.
• Absence of sFLt-1/PlGF ratio result.